| P2093 | author name string | A D Smith | |
| | D R Taylor | |
| | M W Pijnenburg | |
| | J C De Jongste | |
| P2860 | cites work | Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma | Q24675014 |
| | Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath | Q24678621 |
| | Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma | Q24678771 |
| | Characterization of within-subject responses to fluticasone and montelukast in childhood asthma | Q28306277 |
| | Evidence for different subgroups of difficult asthma in children | Q28363315 |
| | Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness | Q28376746 |
| | Respiratory nitric oxide levels in experimental human influenza | Q30472511 |
| | Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. | Q31941303 |
| | The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. | Q33211376 |
| | The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. | Q33211769 |
| | Measurement of exhaled nitric oxide in young children during tidal breathing through a facemask | Q33214422 |
| | Clinical aspects of exhaled nitric oxide | Q34098667 |
| | Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate | Q34128405 |
| | Increased amount of nitric oxide in exhaled air of asthmatics. | Q34290955 |
| | Increased nitric oxide in exhaled air of asthmatic patients | Q34321842 |
| | ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 |
| | Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 |
| | Exhaled Nitric Oxide as a Noninvasive Assessment of Chronic Cough | Q58387536 |
| | Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease | Q58840573 |
| | Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease | Q58877288 |
| | Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients | Q70839028 |
| | Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome | Q71057493 |
| | Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections | Q71694288 |
| | Acute and chronic effects of cigarette smoking on exhaled nitric oxide | Q71704570 |
| | Airway nitric oxide in asthmatic children and patients with cystic fibrosis | Q71939279 |
| | Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis | Q71975001 |
| | Modulation of Airway Epithelial Cell Ciliary Beat Frequency by Nitric Oxide | Q72072683 |
| | Nasally exhaled nitric oxide in humans originates mainly in the paranasal sinuses | Q72122774 |
| | Elevated levels of exhaled nitric oxide in bronchiectasis | Q72279825 |
| | Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide | Q72279828 |
| | A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation | Q73076822 |
| | Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease | Q73167996 |
| | A simple flow-driven method for online measurement of exhaled NO starting at the age of 4 to 5 years | Q73168021 |
| | Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis | Q73208088 |
| | Exhaled nitric oxide and its long-term variation in healthy non-smoking subjects | Q73253304 |
| | The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation | Q73263324 |
| | Airway nitric oxide in infants with acute wheezy bronchitis | Q73280930 |
| | Post-lung transplant bronchiolitis obliterans syndrome (BOS) is characterized by increased exhaled nitric oxide levels and epithelial inducible nitric oxide synthase | Q73286311 |
| | Changes in sputum eosinophils predict loss of asthma control | Q73321300 |
| | Single breath analysis of endogenous nitric oxide in the newborn | Q73379516 |
| | Nitric oxide, iNOS, and inflammation in cystic fibrosis | Q73405571 |
| | Increased exhaled nitric oxide in chronic bronchitis: comparison with asthma and COPD | Q73538167 |
| | Exhaled nitric oxide and exercise in stable COPD patients | Q73538169 |
| | Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years | Q34424366 |
| | Nitric oxide as a unique signaling molecule in the vascular system: a historical overview | Q35038901 |
| | Multiple roles of nitric oxide in the airways. | Q35055532 |
| | Cross sectional study of exhaled nitric oxide levels following lung transplantation | Q35532503 |
| | Nitrite levels in breath condensate of patients with cystic fibrosis is elevated in contrast to exhaled nitric oxide | Q35532597 |
| | Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma | Q35532923 |
| | Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease | Q35533178 |
| | Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease | Q35533230 |
| | Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma | Q35533681 |
| | Controlled low flow off line sampling of exhaled nitric oxide in children | Q35534447 |
| | Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma | Q35534832 |
| | Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids | Q35534841 |
| | Exhaled nitric oxide correlates with airway eosinophils in childhood asthma | Q35535115 |
| | Comparison of airway immunopathology of eosinophilic bronchitis and asthma | Q35535986 |
| | Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission | Q35537520 |
| | Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension | Q35563263 |
| | Decreased exhaled nitric oxide in subjects with HIV infection | Q35563339 |
| | Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 |
| | Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests | Q35564195 |
| | Is exhaled nitric oxide measurement a useful clinical test in asthma? | Q36005806 |
| | Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids | Q36528911 |
| | Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells | Q37387553 |
| | Mucosal inflammation in asthma | Q37946348 |
| | Nitric oxide and bronchial hyperresponsiveness | Q40462252 |
| | Exhaled nitric oxide predicts asthma exacerbation | Q40492844 |
| | Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis | Q40835380 |
| | Exhaled nitric oxide is reduced in infants with cystic fibrosis | Q41907092 |
| | Nitric oxide in chronic airway inflammation in children: diagnostic use and pathophysiological significance | Q42025418 |
| | Nitric oxide metabolites in cystic fibrosis lung disease | Q42279678 |
| | Airway diffusing capacity of nitric oxide and steroid therapy in asthma | Q43498450 |
| | Role of nasal nitric oxide in the resolution of experimental rhinovirus infection | Q43538398 |
| | FeNO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. | Q43545273 |
| | Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 |
| | Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma | Q43766439 |
| | Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone | Q43796653 |
| | Airway inflammation is present during clinical remission of atopic asthma. | Q43819606 |
| | Changes of exhaled nitric oxide during steroid treatment of childhood asthma | Q44056562 |
| | Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship | Q44162549 |
| | Prospective evaluation of the validity of exhaled nitric oxide for the diagnosis of asthma | Q44357077 |
| | Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals. | Q44398397 |
| | Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia | Q44542287 |
| | Smoking cessation is associated with an increase in exhaled nitric oxide | Q73614786 |
| | Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis | Q73781943 |
| | Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis | Q73788224 |
| | Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease | Q73872187 |
| | Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey | Q73896105 |
| | Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension | Q74067840 |
| | Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment | Q74139177 |
| | Off-line sampling of exhaled air for nitric oxide measurement in children: methodological aspects | Q74317639 |
| | Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function | Q74317656 |
| | Exhaled nitric oxide in COPD patients | Q74352323 |
| | Exhaled nitric oxide in chronic obstructive pulmonary disease | Q74363509 |
| | Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects | Q74446321 |
| | Exhaled single-breath nitric oxide measurements are reproducible, repeatable and reflect levels of nitric oxide found in the lower airways | Q74463156 |
| | The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control | Q74493889 |
| | Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness | Q74582008 |
| | Effect of arginine on mucociliary function in primary ciliary dyskinesia | Q77151575 |
| | Exhaled and nasal nitric oxide is increased in laboratory animal allergy | Q77163413 |
| | Relationship between exhaled nitric oxide and childhood asthma | Q77400092 |
| | Exhaled and sputum nitric oxide in bronchiectasis: correlation with clinical parameters | Q77504469 |
| | Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease | Q77586376 |
| | Difficult asthma | Q77720202 |
| | Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma | Q77747395 |
| | Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis | Q77759058 |
| | Exhaled nitric oxide is increased in active fibrosing alveolitis | Q77765567 |
| | NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma | Q78120709 |
| | Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia | Q78120719 |
| | Sampling of exhaled nitric oxide in children: end-expiratory plateau, balloon and tidal breathing methods compared | Q78120723 |
| | A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma | Q79094827 |
| | Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia | Q80937019 |
| | Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children | Q44650811 |
| | Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 |
| | Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome | Q44955938 |
| | Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infants. | Q44993109 |
| | Accuracy of exhaled nitric oxide measurements for the diagnosis of bronchiolitis obliterans syndrome after lung transplantation | Q45061973 |
| | Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids | Q46418165 |
| | Benefit from anti-inflammatory treatment during clinical remission of atopic asthma | Q46476526 |
| | Exhaled nitric oxide: a predictor of steroid response | Q46496987 |
| | Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. | Q46522261 |
| | The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. | Q46530790 |
| | Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial | Q46565002 |
| | Nitric oxide levels in exhaled air and inducible nitric oxide synthase immunolocalization in pulmonary sarcoidosis | Q46785282 |
| | Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations | Q46968826 |
| | Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population‐based sample of children | Q47385665 |
| | High fractional concentration of nitric oxide in exhaled air despite steroid treatment in asthmatic children | Q47766190 |
| | Exhaled nitric oxide from lung periphery is increased in COPD. | Q47770379 |
| | Exhaled NO may predict the decline in lung function in bronchiolitis obliterans syndrome | Q47805286 |
| | Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children | Q47849250 |
| | Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia | Q47911559 |
| | Exhaled nitric oxide as a marker of airway inflammation for an epidemiologic study in schoolchildren | Q47929874 |
| | Exhaled nitric oxide: relation to sensitization and respiratory symptoms | Q48014285 |
| | Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants. | Q50850004 |
| | Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. | Q51466652 |
| | Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome. | Q51527599 |
| | Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. | Q51641626 |
| | Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children. | Q51680181 |
| | The relationship between exhaled nitric oxide and allergic sensitization in a random sample of school children. | Q51686641 |
| | Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia. | Q51687788 |
| | Reduction of variability of exhaled nitric oxide in healthy volunteers. | Q51694486 |
| | Short-term variability of exhaled nitric oxide in young male patients with mild asthma and in healthy subjects. | Q51698331 |
| | Measurement of exhaled nitric oxide in children, 2001. | Q51707949 |
| | Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. | Q51713519 |
| | Exhaled nitric oxide concentrations: online versus offline values in healthy children. | Q51722416 |
| | Increased nitric oxide production in the respiratory tract in asymptomatic pacific islanders: an association with skin prick reactivity to house dust mite. | Q52078768 |
| | Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis. | Q54160564 |
| | Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial | Q55094017 |
| | Non-eosinophilic cor ticosteroid unresponsive asthma | Q55094026 |
| | Exhaled nitric oxide in 4-year-old children: relationship with asthma and atopy | Q58052665 |
| | Exhaled Nitric Oxide Correlated With Induced Sputum Findings in COPD | Q58387520 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 817-27 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Thorax | Q7796158 |
| P1476 | title | Exhaled nitric oxide measurements: clinical application and interpretation | |
| P478 | volume | 61 | |